STOCK MARKET BSE NSE

Pfizer seeking FDA nod for two-shot COVID vaccine booster dose

The drugmaker said Wednesday that it has started the application process for a third dose of its vaccine for people ages 16 and older.

Published: 26th August 2021 11:03 AM  |   Last Updated: 26th August 2021 11:03 AM   |  A+A-

In this March 2021 photo provided by Pfizer, vials of the Pfizer-BioNTech COVID-19 vaccine are prepared for packaging. (Photo | AP)

By PTI

WASHINGTON: Pfizer is seeking US approval of a booster dose of its two-shot COVID-19 vaccine.

The drugmaker said Wednesday that it has started the application process for a third dose of its vaccine for people ages 16 and older.

The company said it will complete the application with the Food and Drug Administration by the end of this week.

The company's move follows an announcement by U.S. health officials last week of plans to give COVID-19 booster shots to all Americans to shore up their protection amid the surging delta variant of the virus.

Officials said it is "very clear" that the vaccines' protection against COVID-19 infections wanes over time.

Pfizer's vaccine received full FDA approval earlier this week; it had been used since last December under an emergency use authorization.

The three vaccines used in the U.S. made by Pfizer, Moderna and Johnson & Johnson are still preventing hospitalizations and deaths from COVID-19.

But the vaccines don't appear quite as strong against the highly contagious delta variant as they were against earlier versions of the virus.

Earlier this month, U.S. regulators said transplant recipients or others with weakened immune systems can get an extra dose of Pfizer or Moderna vaccines.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

edexworks
flipboard facebook twitter whatsapp